Martin Shkreli trial: Court struggles to find impartial jurors

A US pharmaceutical company executive who became a symbol of industry greed is about to stand trial for securities fraud.

by

    A US pharmaceutical company executive who became a symbol of industry greed is about to stand trial for securities fraud.

    But, given Martin Shkreli's notoriety for price gouging, the court has struggled to find jurors who can be impartial.

    So far more than 250 potential jurors have been dismissed because they have strong objections to the defendant.

    Al Jazeera's Kristen Saloomey reports from New York.


    YOU MIGHT ALSO LIKE

    'We will cut your throats': The anatomy of Greece's lynch mobs

    The brutality of Greece's racist lynch mobs

    With anti-migrant violence hitting a fever pitch, victims ask why Greek authorities have carried out so few arrests.

    The rise of Pakistan's 'burger' generation

    The rise of Pakistan's 'burger' generation

    How a homegrown burger joint pioneered a food revolution and decades later gave a young, politicised class its identity.

    From Cameroon to US-Mexico border: 'We saw corpses along the way'

    'We saw corpses along the way'

    Kombo Yannick is one of the many African asylum seekers braving the longer Latin America route to the US.